This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
LYPD3 Antibodies
AND LYPD3 ELISA kits, LYPD3 Proteins
Many biological assays use antibodies to detect LYPD3, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with LYPD3 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop LYPD3 antibodies...
Previous: SEPTIN9
Next: B9D1
LYPD3 Infographic by Boster Bio
All LYPD3 Products
Product
Figures
Specificity
Applications
Price
Mouse
ELISA
$750
Cat # EK1838
96 wells/kit, with removable strips.
Cat # EK1838
96 wells/kit, with removable strips.
Human
ELISA
$750
Cat # EK1837
96 wells/kit, with removable strips.
Cat # EK1837
96 wells/kit, with removable strips.
Human, Mouse, Rat
ELISA, Flow Cytometry, IF, IHC, WB
$370
Cat # A08396
100 µg/vial
Cat # A08396
100 µg/vial
LYPD3 Overview
Facts about Ly6/PLAUR domain-containing protein 3.
Ly6/PLAUR domain-containing protein 3 (LYPD3)
Supports cell migration. May be involved in urothelial cell-matrix interactions.
May be involved in tumor development. .
Gene Information
| Human | |
|---|---|
| Gene Name: | LYPD3 |
| Uniprot: | O95274 |
| Entrez: | 27076 |
Family
| Belongs to: |
|---|
| No superfamily |
Alternative Names
C4.4A; C4.4A2310061G07Rik; GPI-anchored metastasis-associated protein C4.4A homolog; GPI-anchored metastasis-associated protein homolog; LY6/PLAUR domain containing 3; ly6/PLAUR domain-containing protein 3; LYPD3; Matrigel-induced gene C4 protein; MIG-C4
Molecular Weight
Mass (kDA):
35.971 kDA
Genomic Context
| Human | |
|---|---|
| Location: | 19q13.31 |
| Sequence: | 19; NC_000019.10 (43460787..43465608, complement) |
Tissue Specificity
Expressed in placenta, skin and urothelium. Found in suprabasal keratinocytes of chronic wounds. Weak expression is found in esophagus and peripheral blood mononuclear cells. Found in the majority of primary and metastatic transitional cell carcinomas (TCCs) and as well in breast cancer tissues, but not in adjacent normal tissues. High expression is found in the tumor component of some noninvasive superficial lesions and in invasive and metastatic urothelial cancers.
Subcellular Localizations
Cell membrane; Lipid-anchor, GPI-anchor.
Diseases
- Neoplasms
- Malignant Neoplasms
- Neoplasm Metastasis
- Carcinoma
- Cell Invasion
- Adenocarcinoma
- Neoplasm Invasiveness
- Mammary Neoplasms
- Esophageal Neoplasms
- Colorectal Neoplasms
- Tumor Progression
- Colorectal Cancer
Pathways
- Wound Healing
- Cell Migration
- Methylation
- Aging
- Glycosylation
- Dna Methylation
- Cell Growth
PTMs
- Glycosylation
- Cleavage
For details, visit:
bosterbio.com/bosterbio-gene-info-cards/LYPD3
bosterbio.com/bosterbio-gene-info-cards/LYPD3
References
PMID: 11245483 by Smith B.A., et al. Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium.
PMID: 11179665 by Wuerfel J., et al. Cloning of the human homologue of the metastasis-associated rat C4.4A.